Document Detail


HCV therapy in HIV-infected patients.
MedLine Citation:
PMID:  23286848     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Hepatitis C virus (HCV) co-infection is common among HIV-infected patients. Over the past 15 years, effective HIV treatment has led to dramatic reductions in the incidence of AIDS-related death; over the same time period, HCV-related liver disease has emerged as a major cause of morbidity and mortality. Treatment with peginterferon (PEG-IFN) and ribavirin (RBV) has been recommended for the treatment of HCV infection in HIV-infected patients at the greatest risk of developing liver disease. However, the effectiveness of this HCV treatment has been low because of limited efficacy in patients infected with HCV genotype 1. More recently, HCV NS3/4A protease inhibitors, telaprevir and boceprevir, in combination with PEG-IFN/RBV have led to significantly higher sustained viral response rates in HIV-uninfected patients with HCV genotype 1 infection. The potential use of these agents in patients with HIV/HCV co-infection is complicated by the potential for drug interactions between antiretroviral drugs and the HCV protease inhibitors and uncertainty regarding the safety and effectiveness of the combination therapy in this population.
Authors:
Mark S Sulkowski
Related Documents :
12627048 - Stress management and psychoneuroimmunology in hiv infection.
25000718 - Cloacolithiasis and intestinal lymphosarcoma in an african black-footed penguin (spheni...
23295258 - Lipid profile changes by high activity anti-retroviral therapy.
23960718 - The prevalence of hcv antibodies in skin disease patients in saudi arabia.
16736948 - Hiv transmission and primary drug resistance.
12748798 - Plasma endothelin-1 levels in patients with biliary atresia: possible role in developme...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  33 Suppl 1     ISSN:  1478-3231     ISO Abbreviation:  Liver Int.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  63-7     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Affiliation:
Johns Hopkins University School of Medicine, Baltimore, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current management and perspectives for HCV recurrence after liver transplantation.
Next Document:  Best strategies for global HCV eradication.